262 related articles for article (PubMed ID: 16720343)
1. Epstein-Barr virus (EBV) and its associated human cancers--genetics, epigenetics, pathobiology and novel therapeutics.
Tao Q; Young LS; Woodman CB; Murray PG
Front Biosci; 2006 Sep; 11():2672-713. PubMed ID: 16720343
[TBL] [Abstract][Full Text] [Related]
2. The Role of the Epstein-Barr virus in human disease.
Murray PG; Young LS
Front Biosci; 2002 Feb; 7():d519-40. PubMed ID: 11815292
[TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr virus-encoded EBNA1 and ZEBRA: targets for therapeutic strategies against EBV-carrying cancers.
Daskalogianni C; Pyndiah S; Apcher S; Mazars A; Manoury B; Ammari N; Nylander K; Voisset C; Blondel M; Fåhraeus R
J Pathol; 2015 Jan; 235(2):334-41. PubMed ID: 25186125
[TBL] [Abstract][Full Text] [Related]
4. Epstein-Barr virus lytic reactivation regulation and its pathogenic role in carcinogenesis.
Li H; Liu S; Hu J; Luo X; Li N; M Bode A; Cao Y
Int J Biol Sci; 2016; 12(11):1309-1318. PubMed ID: 27877083
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic dysregulation of the host cell genome in Epstein-Barr virus-associated neoplasia.
Niller HH; Wolf H; Minarovits J
Semin Cancer Biol; 2009 Jun; 19(3):158-64. PubMed ID: 19429479
[TBL] [Abstract][Full Text] [Related]
6. [Mechanisms of Epstein-Barr Virus-Mediated Oncogenesis].
Iwakiri D
Gan To Kagaku Ryoho; 2015 Oct; 42(10):1133-6. PubMed ID: 26489540
[TBL] [Abstract][Full Text] [Related]
7. Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases.
Niller HH; Wolf H; Minarovits J
Autoimmunity; 2008 May; 41(4):298-328. PubMed ID: 18432410
[TBL] [Abstract][Full Text] [Related]
8. Human B cells on their route to latent infection--early but transient expression of lytic genes of Epstein-Barr virus.
Kalla M; Hammerschmidt W
Eur J Cell Biol; 2012 Jan; 91(1):65-9. PubMed ID: 21450364
[TBL] [Abstract][Full Text] [Related]
9. New strategies and patent therapeutics in EBV-associated diseases.
Villegas E; Santiago O; Sorlózano A; Gutierrez J
Mini Rev Med Chem; 2010 Sep; 10(10):914-27. PubMed ID: 21034415
[TBL] [Abstract][Full Text] [Related]
10. Integrative identification of Epstein-Barr virus-associated mutations and epigenetic alterations in gastric cancer.
Liang Q; Yao X; Tang S; Zhang J; Yau TO; Li X; Tang CM; Kang W; Lung RW; Li JW; Chan TF; Xing R; Lu Y; Lo KW; Wong N; To KF; Yu C; Chan FK; Sung JJ; Yu J
Gastroenterology; 2014 Dec; 147(6):1350-62.e4. PubMed ID: 25173755
[TBL] [Abstract][Full Text] [Related]
11. Current Trends and Alternative Scenarios in EBV Research.
Minarovits J; Niller HH
Methods Mol Biol; 2017; 1532():1-32. PubMed ID: 27873264
[TBL] [Abstract][Full Text] [Related]
12. Genome-wide profiling of Epstein-Barr virus integration by targeted sequencing in Epstein-Barr virus associated malignancies.
Xu M; Zhang WL; Zhu Q; Zhang S; Yao YY; Xiang T; Feng QS; Zhang Z; Peng RJ; Jia WH; He GP; Feng L; Zeng ZL; Luo B; Xu RH; Zeng MS; Zhao WL; Chen SJ; Zeng YX; Jiao Y
Theranostics; 2019; 9(4):1115-1124. PubMed ID: 30867819
[No Abstract] [Full Text] [Related]
13. EBV-Related Malignancies, Outcomes and Novel Prevention Strategies.
Ozoya OO; Sokol L; Dalia S
Infect Disord Drug Targets; 2016; 16(1):4-21. PubMed ID: 27052336
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic Alterations in Epstein-Barr Virus-Associated Diseases.
Niller HH; Banati F; Salamon D; Minarovits J
Adv Exp Med Biol; 2016; 879():39-69. PubMed ID: 26659263
[TBL] [Abstract][Full Text] [Related]
15. The Epstein-Barr virus and its association with human cancers.
Baumforth KR; Young LS; Flavell KJ; Constandinou C; Murray PG
Mol Pathol; 1999 Dec; 52(6):307-22. PubMed ID: 10748864
[TBL] [Abstract][Full Text] [Related]
16. Transcriptional profiling of Epstein-Barr virus (EBV) genes and host cellular genes in nasal NK/T-cell lymphoma and chronic active EBV infection.
Zhang Y; Ohyashiki JH; Takaku T; Shimizu N; Ohyashiki K
Br J Cancer; 2006 Feb; 94(4):599-608. PubMed ID: 16449999
[TBL] [Abstract][Full Text] [Related]
17. Epstein-Barr virus infection and nasopharyngeal carcinoma: the other side of the coin.
Perri F; Della Vittoria Scarpati G; Giuliano M; D'Aniello C; Gnoni A; Cavaliere C; Licchetta A; Pisconti S
Anticancer Drugs; 2015 Nov; 26(10):1017-25. PubMed ID: 26241803
[TBL] [Abstract][Full Text] [Related]
18. Viral Carcinogenesis Beyond Malignant Transformation: EBV in the Progression of Human Cancers.
Elgui de Oliveira D; Müller-Coan BG; Pagano JS
Trends Microbiol; 2016 Aug; 24(8):649-664. PubMed ID: 27068530
[TBL] [Abstract][Full Text] [Related]
19. The roles of DNA methylation on the promotor of the Epstein-Barr virus (EBV) gene and the genome in patients with EBV-associated diseases.
Zhang L; Wang R; Xie Z
Appl Microbiol Biotechnol; 2022 Jun; 106(12):4413-4426. PubMed ID: 35763069
[TBL] [Abstract][Full Text] [Related]
20. Epstein-Barr virus (EBV) status in colorectal cancer: a mini review.
Bedri S; Sultan AA; Alkhalaf M; Al Moustafa AE; Vranic S
Hum Vaccin Immunother; 2019; 15(3):603-610. PubMed ID: 30380978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
